Acumen Pharmaceuticals Net Debt Growth & History (ABOS)

Acumen Pharmaceuticals's net debt was −$22.7M for fiscal 2025.

View full Acumen Pharmaceuticals company overview

Acumen Pharmaceuticals annual net debt history

Acumen Pharmaceuticals annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$22.7M−$16.8M
20242024-12-31−$5.9M$29.9M
20232023-12-31−$35.8M$94.2M
20222022-12-31−$130.0M−$7.8M
20212021-12-31−$122.2M

Acumen Pharmaceuticals net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Acumen Pharmaceuticals's net debt increased from −$122.2M to −$22.7M, a change of $99.5M. The latest reported quarter, Q2 2026, shows −$27.8M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Acumen Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about ABOS yet. Start the conversation.

Write the first post